Supplements for suckling calves and supplements for weaning calves to improve symptoms or conditions of calves
Supplementing calves with lysine during lactation and bypass-processed lysine during weaning addresses health issues by enhancing weight gain, forage intake, and reducing stress-related health problems, improving overall calf health.
Patent Information
- Application Number
- JP2022165759
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2022-10-14
- Publication Date
- 2024-11-13
- Estimated Expiration
- 2042-10-14
AI Technical Summary
Calves experience health issues during lactation and weaning due to stress, leading to weight loss, weakened immune systems, and increased cortisol levels, which existing feed additives have not effectively addressed.
Supplementing lactating calves with unprocessed lysine during lactation and bypass-processed lysine during weaning to improve health conditions, including feeding 0.75-6g/day of lysine and 0.35-4g/day of bypass lysine, respectively, without combining with methionine.
Lysine supplementation enhances body weight gain, forage intake, gluconeogenesis, reduces white blood cell count changes, suppresses the N:L ratio, and decreases treatment days, thereby improving calf health during both periods.
Smart Images

Figure 0007582688000004 
Figure 0007582688000005 
Figure 0007582688000006
Abstract
Description
[Technical field]
[0001] The present invention relates to a supplement for suckling calves for improving symptoms or conditions of calves during the suckling period, a supplement for weaning calves for improving symptoms or conditions of calves following weaning, and a calf supplement set that combines these. [Background technology]
[0002] Excessive stress in livestock not only causes problems in terms of animal welfare, but also leads to reduced productivity and deterioration in the quality of livestock products. In the case of calves, they are forced to endure various social and environmental stresses, such as separation from their mothers, weaning, changes in feed, and changes in rearing environment, which are known to cause health problems such as weight loss and reduced immunity. Physiological responses associated with weaning include an increase in plasma cortisol concentration (Non-Patent Document 1) and an increase in the ratio of neutrophils to lymphocytes (N / L ratio) (Non-Patent Document 2).
[0003] On the other hand, various feed additives that have been processed to bypass the rumen (bypass processing) so as not to be decomposed by microorganisms in the rumen of ruminants are used (for example, Patent Document 1), and bypass-processed lysine (hereinafter sometimes referred to as bypass lysine) is also known (Patent Documents 2 to 4). Bypass lysine is used as a feed additive that supplements lysine, which is easily deficient in dairy cows, and improves lactation performance (Non-Patent Document 3). In addition, a product that uses lysine and methionine in combination is known as a feed additive for cows that not only improves milk yield and milk protein production, but also improves reproductive performance and has an effect against fatty liver and ketosis (Non-Patent Document 4).
[0004] Regarding lysine and stress in animals, it is known that, for example, lysine deficiency in rats increases serotonin release in the amygdala, increasing stress-induced anxiety symptoms (Non-Patent Document 5), and oral supplementation of lysine and arginine reduces anxiety symptoms in humans (Non-Patent Document 6).
[0005] As a report on feeding lysine to calves in the suckling to weaning period, for example, Non-Patent Document 7 describes that by adding lysine to a starter (also called artificial milk or concentrated feed) with 18% crude protein and having calves ingest 6.640 g of lysine per day, the daily weight gain before weaning was significantly increased compared to when a starter without lysine was fed, but there was no effect on the daily weight gain after weaning. Non-Patent Document 8 describes that a test was conducted in which lysine and methionine were administered in combination to weaned calves, and a test in which lysine was administered alone, with the aim of investigating the effect of lysine and methionine supplementation on the nitrogen balance and blood free amino acids of calves after early weaning. Data on daily weight gain is also shown, but a significant weight gain promotion effect was observed when lysine and methionine were used in combination, and no weight gain promotion effect was observed when lysine was used alone. [Prior art documents] [Patent documents]
[0006] [Patent Document 1] JP 2020-145962 A [Patent Document 2] Patent No. 3728738 [Patent Document 3] Patent No. 5040919 [Patent Document 4] International Publication No. 2019 / 189605 [Non-patent literature]
[0007] [Non-Patent Document 1] Lay et al. Applied Animal Behavior Science, 56 (1998), pp. 109-119 [Non-Patent Document 2] Hickey et al., J Anim Sci, 81: 2847-2855 (2003). [Non-Patent Document 3] Ajinomoto Healthy Supply Co., Ltd., “AjiPro(R)-L Lysine Preparation for Dairy Cows,” [Retrieved August 26, 2022], Internet<URL: https: / / www.ahs.ajinomoto.com / products / feed / feed_4.html> [Non-Patent Document 4] Bio Science Co., Ltd., "Bypass Supplement "Milk Liver Plus Lysine"," [Retrieved August 26, 2022], Internet <URL: https: / / www.bioscience.co.jp / products / livestock / %E3%83%9F%E3%83%AB%E3%82%AB%E3%83%B3-%E3%83%AA%E3%82%B8%E3%83%B3 / > [Non-Patent Document 5] Smriga et al., The Journal of Nutrition, December 2002, Volume 132, Issue 12, Pages 3744-3746 [Non-Patent Document 6] Smriga et al., Biomedical Research, 2007, Volume 28, Issue 2, Pages 85-90 [Non-Patent Document 7] Niroumand et al., South African Journal of Animal Science 2020, 50 (No. 3), pp.442-451 [Non-Patent Document 8] Abe et al., Anim. Sci. Technol. (Jpn.) 67 (12): 1058-1067, 1996 Summary of the Invention [Problem to be solved by the invention]
[0008] An object of the present invention is to provide a novel means useful for alleviating symptoms that tend to occur in calves during the suckling period, symptoms caused by weaning stress, and adverse effects on health conditions. [Means for solving the problem]
[0009] As a result of intensive research, the present inventors have found that the above problems in calves during the suckling to weaning period can be solved by supplementing calves with lysine during the suckling period and by supplementing calves with bypass lysine during the weaning period, and have completed the present invention. That is, the present invention relates to the use of lysine as a supplement for suckling calves to improve symptoms or conditions of calves during the suckling period, and the use of bypass lysine as a supplement for weaning calves to improve symptoms or conditions of calves associated with weaning, and includes the following aspects.
[0010] [ 1 ] Use of a weaning calf supplement containing bypass-processed lysine to improve a symptom or condition of a calf associated with weaning by supplementing the weaning calf with bypass-processed lysine in an amount of 0.35 g to 4 g per day, calculated as lysine, without combining it with either methionine or bypass-processed methionine. [ 2 The improvement in the symptom or condition is at least one selected from the group consisting of an improvement in body weight gain, an improvement in roughage intake, an improvement in gluconeogenesis, a reduction in changes in white blood cell count and an inhibition of an increase in the N:L ratio, and a reduction in the number of days of treatment. 1 ]Use as described. [ 3 ] A method for improving a symptom or condition of a calf associated with weaning, comprising feeding a weaning calf a weaning calf supplement containing bypassed lysine in an amount of 0.35 g to 4 g per day, calculated as lysine, without combining it with either methionine or bypassed methionine. [ 4 The improvement in the symptom or condition is at least one selected from the group consisting of an improvement in body weight gain, an improvement in roughage intake, an improvement in gluconeogenesis, a reduction in changes in white blood cell count and an inhibition of an increase in the N:L ratio, and a reduction in the number of days of treatment. 3 ]The method described. [ 5A method for improving a symptom or condition of a calf during the suckling period or following weaning, comprising: feeding said calf in the suckling period 0.75 g to 6 g of lysine as a supplement per day; and feeding said calf in the weaning period bypassed lysine as a supplement per day. , in combination with neither methionine nor bypassed methionine, The method includes providing the animal in an amount of 0.35 g to 4 g per day calculated as lysine. [ 6 ] The amount of lysine fed to the calf during the suckling period is 2 g to 6 g per day. 5 ]The method described. Effect of the Invention
[0011] Among the present inventions, the invention of feeding non-bypassed lysine can reduce symptoms that tend to occur in calves during the suckling period, and improve or enhance the health of calves during the suckling period. The invention of feeding bypass lysine can reduce symptoms and adverse effects on health caused by weaning stress, and improve or enhance the health of calves during the weaning period. Furthermore, by combining these, the health of calves from the suckling period to the weaning period can be improved or enhanced. [Brief description of the drawings]
[0012] [Figure 1] The milk replacer feeding system for the calves used in the study. [Figure 2-1] Body weight of the Lys group and the control group. [Figure 2-2] Average daily weight gain in the Lys and control groups. [Figure 2-3] Average daily gain by stage in the Lys and control groups. [Figure 3-1] Artificial milk intake in the Lys and control groups. [Figure 3-2] Total artificial milk intake by stage in the Lys and control groups. [Figure 3-3] Roughage intake in the Lys and control groups. [Diagram 3-4] Total roughage intake by stage in the Lys and control groups. †: P<0.10, *: P<0.05 [Figure 4-1] Feed efficiency in the Lys group and the control group. †: P<0.10, *: P<0.05 [Figure 4-2] Feed efficiency by stage in the Lys group and the control group. †: P<0.10, *: P<0.05 [Diagram 5] Serum lysine concentration in the Lys group and the control group. *: P<0.05 [Figure 6] Number of days of treatment by stage in the Lys group and the control group. †: P<0.10 DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0013] In the present invention, the invention in which non-bypassed lysine is fed targets calves in the suckling stage, and the invention in which bypassed lysine is fed targets calves in the weaning stage. Both include calves of milk-producing breeds (dairy cows) such as Holstein and Jersey, and calves of meat-producing breeds (beef cattle) such as Japanese Black. The calves may be those that are separated from their mothers early after birth and ingestion of colostrum and are artificially fed with milk replacer (liquid feed) and artificial milk (solid feed, also called starter), or they may be naturally fed calves that are not separated from their mothers until weaning and are fed by breastfeeding from the mother cow, or they may be calves under feeding control in which the time that the mother and calf live together is limited or the number of times that they are fed by the mother cow is limited by means of a fence separating the mother and calf. The calves may be raised alone or in groups, and it does not matter whether an automatic feeding machine for milk replacer is used or not. In dairy farming, early separation of mother and calf from one another is the norm, and artificial feeding is becoming more common in livestock farming as well.
[0014] The suckling period is the period during which liquid feed such as milk replacer or breast milk is given before weaning, and it is the period from 0 weeks of age until weaning. During this period, not only liquid feed but also artificial milk and roughage are given as solid feed. The weaning period is the period after weaning during which artificial milk and roughage are given, and it is generally the period from weaning to about 10 weeks after weaning. The weaning period is set appropriately for each farm depending on the feeding management method, but in artificial feeding management with early mother-calf separation, weaning is generally done at 6 to 12 weeks of age. In natural feeding of beef cattle, weaning is generally done at about 3 months of age.
[0015] The supplement for suckling calves for improving the symptoms or condition of suckling calves according to the present invention contains lysine and is used to supply 0.75 g to 6 g of lysine per day to suckling calves. The amount of lysine supplied by the supplement per day is not particularly limited as long as it is within the range of 0.75 g to 6 g, but may be, for example, 1 g to 6 g, 1.2 g to 6 g, 1.5 g to 6 g, 1.7 g to 6 g, 2 g to 6 g, 2.2 g to 6 g, 2.5 g to 6 g, 2.7 g to 6 g, 3 g to 6 g, 3.2 g to 6 g, or 3.5 g to 6 g. The upper limit of the supply amount may be 5.5 g or 5 g. During the supply period of the supplement for suckling calves, it is preferable to supply the supplement in the amount of lysine described above every day. The daily amount may be supplied in multiple portions, but it is convenient and preferable to supply it in one portion.
[0016] Calves during the suckling period take in lysine from feed, mainly from breast milk or milk replacer, and artificial milk, but in the present invention, the above-mentioned amount of lysine is additionally supplied by the supplement. The daily lysine intake of a suckling calf, which is the sum of the lysine intake from feed and the lysine intake from the supplement for suckling calves of the present invention, varies depending on the lysine content of the breast milk or milk replacer or artificial milk given to the calf, so is not particularly limited, and may be, for example, about 10 g to 40 g, about 11 g to 40 g, or about 12 g to 40 g.
[0017] The improvement of the symptoms or condition of a calf during the suckling period by a supplement for suckling calves is, for example, at least one selected from an increase in weight gain (e.g., daily weight gain or average daily weight gain) during the suckling period and an increase in roughage intake.
[0018] The period during which the suckling calf supplement is fed to suckling calves may be at least from 3 weeks before weaning until weaning, for example, from 25 days before weaning until weaning, or from 4 weeks before weaning until weaning.
[0019] The suckling calf supplement contains lysine in a non-bypassed form and may consist essentially of lysine or may further contain additives that have no rumen bypass effect. In one embodiment, the suckling calf supplement is used without combination with either methionine or bypassed methionine.
[0020] The supplement for suckling calves may be added to feed such as milk replacer, or may be given orally without being added to feed, directly or by dissolving in drinking water. The supplement can also be provided in a form added to feed for suckling calves such as milk replacer.
[0021] The supplement for weaning calves for improving the symptoms or condition of calves associated with weaning according to the present invention contains bypassed lysine (bypassed lysine) and is used to supply bypassed lysine in an amount of 0.35 g to 4 g per day in terms of lysine to weaning calves. The amount of lysine supplied by the supplement per day is not particularly limited as long as it is within the range of 0.35 g to 4 g, but may be, for example, 0.5 g to 4 g, 0.7 g to 4 g, 1 g to 4 g, 1.2 g to 4 g, or 1.5 g to 4 g, and the upper limit may be 3.7 g, 3.5 g, 3.2 g, 3 g, 2.7 g, or 2.5 g. During the supply period of the supplement for weaning calves, it is preferable to feed the supplement in the above amount in terms of lysine every day. The daily amount may be fed in multiple portions, but it is convenient and preferable to feed it in one portion.
[0022] After weaning, the rumen develops, but in the present invention, the bypass lysine is supplemented to weaning calves in order to have the calf absorb lysine, not as a nutrient source for ruminal microorganisms. The bypass process itself, which bypasses the rumen, is well known in the art. For example, the bypass process can be performed by spray coating or pan coating the raw material used in the bypass process, such as hardened oil. Since bypass lysine is commercially available, the present invention can also be carried out using a commercially available product.
[0023] The period during which the weaning calf supplement is fed to weaning calves may be at least from weaning to two weeks after weaning, and may be, for example, a period from weaning to 18 days after weaning, or a period from weaning to three weeks after weaning.
[0024] The improvement of symptoms or conditions of calves associated with weaning by a supplement for weaning calves is, for example, at least one selected from increased weight gain, increased roughage intake, improved gluconeogenesis, reduced changes in white blood cell count and suppression of increases in the N:L ratio, and reduced number of days of treatment during the weaning period.
[0025] The weaning calf supplement contains bypassed lysine and may consist essentially of bypassed lysine alone, or may further contain additives that do not impair the rumen bypass effect. In one embodiment, the weaning calf supplement is used without combination with either methionine or bypassed methionine.
[0026] The supplement for weaning calves of the present invention may be added to feed such as artificial milk or roughage, or may be given orally without being added to feed, directly or by dissolving in drinking water. The supplement can also be provided in a form added to feed for weaning calves such as artificial milk.
[0027] The suckling calf supplement and weaning calf supplement of the present invention may be provided in combination as a calf supplement.
[0028] In the method for improving a symptom or condition of a calf during the suckling period or associated with weaning according to the present invention, a calf is fed a supplement for suckling calves in an amount of 0.75 g to 6 g per day calculated as lysine during the suckling period, and a supplement for weaning calves in an amount of 0.35 g to 4 g per day calculated as lysine during the weaning period. The improvement of the symptom or condition of a calf during the suckling period or associated with weaning by the method is, for example, at least one selected from improved weight gain during the suckling period and weaning period, improved roughage intake during the suckling period and weaning period, improved gluconeogenesis during the weaning period, reduced changes in white blood cell count and suppressed increases in the N:L ratio during the weaning period, and reduced number of days of treatment during the weaning period. EXAMPLES
[0029] The present invention will be described in more detail below with reference to examples, although the present invention is not limited to the following examples.
[0030] Example: Effect of lysine supplementation on reducing weaning stress 1. Materials and Methods (a) Examination period: March 2021 to June 2021 (a) Test location: Kasama Dairy and Beef Cattle Laboratory, Nursing House (c) Test animals: 20 4-week-old Holstein female calves (separated from their mothers within one hour of birth) (e) Test division: The following two divisions were set up (n=10 for each division). a. Control group: The animals were managed according to the farm's practices (milk replacer was fed as shown in Figure 1, and solid feed (artificial milk and roughage) was fed throughout the entire period). The test period was 6 weeks in total, with the lactation period being from 0 to 3 weeks (4 to 7 weeks of age) and the weaning period being from 4 to 6 weeks (8 to 10 weeks of age). b. Lysine group: In addition to the control group, lysine (product name L-lysine hydrochloride, manufactured by Xinjiang Meihua Amino Acid Co., Ltd., main component lysine (content rate 98.5%)) was orally supplemented at 4 g / head / day (equivalent to 3.94 g / head / day of lysine) until the third week, and bypass lysine (product name Spray Lysine, manufactured by Bioscreen Technologies Srl, main component lysine, content rate 40%, bypass rate 80%) was orally supplemented at 4 g / head / day of the original (equivalent to 1.6 g / head / day of lysine) from the fourth week onwards. The feeding amounts of lysine and bypass lysine were preliminary examined and set at 4 g / head / day of the original for both, based on the amount at which the blood lysine concentration increased. (E) Feeding and management: Feed was given twice a day and water was allowed ad libitum. Treatment, vaccinations, dehorning, and other management were carried out in accordance with the farm rules.
[0031] (F) Survey items: a. Feed intake; daily b. Body weight; weekly c. Biochemical tests: Blood was drawn at the same time as body weight was measured, and the serum after centrifugation was used to measure TP, Alb, AST, γ-GTP, BUN, Tcho, glucose (Glu), cortisol, white blood cell count, white blood cell differential, and free amino acid concentration. (G) Statistical analysis: All data was subjected to two-way repeated measures analysis of variance with treatment and time as factors using model fitting in JMP Ver. 15. When significant differences (P<0.05) were found, Student t-test was performed. Average daily gain (ADG), feed intake, feed efficiency, white blood cell count, and white blood cell differential calculated based on body weight were divided into suckling, weaning, and all periods, and Student t-test was performed for the differences between each period.
[0032] 2. Results and Discussion (A) Weight (Figures 2-1 to 2-3) The body weight of the Lys group increased significantly or showed a tendency to increase from the 4th week of the experiment onwards compared to the control group. During the 3rd-4th and 5th-6th weeks of the experiment, the DG of the Lys group was higher than that of the control group, and even when divided by stage, the DG of the Lys group was higher than that of the control group at both the suckling and weaning stages. These data suggest that lysine supplementation of calves increases ADG during the suckling period.
[0033] (a) Feed intake (Fig. 3-1 to Fig. 3-4) There was no difference in the amount of artificial milk intake between the groups, and the amount of artificial milk intake was not affected by lysine feeding (Figures 3-1 and 3-2). Regarding roughage intake, lysine did not affect the change in roughage intake over time, but the Lys group tended to have a higher intake than the control group throughout the entire test period (Figure 3-3). When viewed by stage, the total roughage intake of the Lys group during the suckling, weaning, and entire test period was significantly higher or showed a tendency to increase compared to the total roughage intake of the control group (Figure 3-4). These data suggest that lysine supplementation of calves improves roughage intake throughout the entire test period.
[0034] (c) Feed efficiency (Figures 4-1 and 4-2) Feed efficiency in the Lys group was not different from that in the control group at 3 and 5 weeks after the start of the study, but was higher in the Lys group than in the control group at 4 and 6 weeks. When analyzed by stage, feed efficiency in the Lys group was higher than that of the control group during the lactation period and the entire study period. These results suggest that lysine supplementation improves feed efficiency in calves during the lactation period.
[0035] (D) Blood components (biochemical tests) (Table 1) The Glu concentration in the Lys group was higher than that in the control group during weeks 2-6 of the study. This result suggests that lysine supplementation in calves promotes gluconeogenesis and increases serum Glu concentration. Cortisol concentrations in the Lys group were lower than those in the control group during weeks 2, 6, and 7 of the study. Therefore, lysine supplementation may partially attenuate the increase in cortisol concentration caused by weaning stress.
[0036] [Table 1]
[0037] (E) Blood components (white blood cell fraction) (Table 2-1, Table 2-2) The N:L ratio in the Lys group was lower than that in the control group at 4-6 weeks of the study. Lysine supplementation may reduce the inflammatory response after weaning. On the other hand, when compared by stage, the Lys group showed higher white blood cell and lymphocyte counts at weaning and throughout the period, higher monocyte counts at suckling and throughout the period, lower eosinophil and neutrophil counts at weaning, and a lower N:L ratio at weaning, compared to the control group. The increase in white blood cell count in the Lys group is thought to be the result of an increase in lymphocyte count. It is known that weaning reduces the blood lymphocyte count, increases the neutrophil count, and increases the N:L ratio in calves (Hickey et al., J Anim Sci, 81: 2847-2855 (2003).), and it was suggested that lysine supplementation to calves reduces the decrease in blood lymphocyte count, increase in neutrophil count, and increase in N:L ratio due to weaning.
[0038] [Table 2-1]
[0039] [Table 2-2]
[0040] (f) Serum lysine concentration (Figure 5) The serum lysine concentration in the Lys group was higher than that in the control group from the 4th to 6th weeks of the study. The serum lysine concentration decreased with a decrease in the amount of milk replacer consumed. No effect of lysine supplementation was observed during the milk replacer feeding period. It is presumed that because lysine supplementation from milk replacer is a greater source of lysine than lysine supplementation from additives, the amount of milk replacer fed had a greater effect on serum lysine concentration during the lactation period, masking the effect of lysine supplementation from additives.
[0041] The lysine content of the amino acid composition of the milk replacer used in this study was 2.35%, and since 0.4-0.8 kg of milk replacer was given per day, the suckling calves were ingesting 9.4-18.8 g / day of lysine from the milk replacer. The lysine content of the amino acid composition of the artificial milk used in this study was 1.07%, and the intake of artificial milk was 60-1,774 g / day during the suckling period and 849-1,900 g / day during the weaning period. In this study, the suckling calves were ingesting 0.642-18.985 g / day of lysine from artificial milk, and the weanling calves were ingesting 9.08-20.33 g / day of lysine from artificial milk. In this study, the amount of lysine ingested by the suckling calves from feed (milk replacer, artificial milk) was 12.70-30.16 g / day. At the time of weaning, the rumen has developed to a certain extent and normal lysine is broken down in the rumen. Therefore, it is thought that the increase in serum lysine concentration in weaned calves is due to the bypass lysine orally ingested as an additive.
[0042] (G) Number of days of treatment (Figure 6) The treatments given to the control group were bloody stools, diarrhea, fever, and coughing, listed in order of frequency. The treatment given to the Lys group was bloody stools only. There was no difference in the number of days of treatment during the suckling period. The number of days of treatment during the weaning period in the Lys group tended to be lower than in the control group. The number of days of treatment during the entire test period also tended to be lower in the Lys group.
[0043] 3. Conclusion Lysine supplementation improved calf ADG throughout the entire period, forage intake, and gluconeogenesis at weaning, increased lymphocyte counts, decreased neutrophil counts, and decreased N:L ratios at weaning, and reduced the number of treatment days at weaning.
Claims
1. Use of a weaning calf supplement containing bypass processed lysine to improve a symptom or condition of a calf associated with weaning by supplementing the weaning calf with bypass processed lysine in an amount of 0.35 g to 4 g per day, calculated as lysine, without combining methionine or bypass processed methionine.
2. The use according to claim 1, wherein the improvement of the symptoms or conditions is at least one selected from the group consisting of improved body weight gain, improved roughage intake, improved gluconeogenesis, reduced changes in white blood cell count and suppression of increases in the N:L ratio, and reduced number of days of treatment.
3. A method for improving a symptom or condition of a weaning calf, comprising feeding a weaning calf a weaning calf supplement containing bypassed lysine in an amount of 0.35 g to 4 g of lysine per day, without combining it with either methionine or bypassed methionine.
4. The method according to claim 3, wherein the improvement in the symptom or condition is at least one selected from the group consisting of improved body weight gain, improved roughage intake, improved gluconeogenesis, reduced changes in white blood cell count and suppression of increases in the N:L ratio, and reduced number of days of treatment.
5. 1. A method for improving a symptom or condition of a calf during the suckling period or following weaning, comprising: feeding the suckling calf a lysine supplement in an amount of 0.75 g to 6 g per day; and feeding the weaning calf a bypassed lysine supplement in an amount of 0.35 g to 4 g per day, calculated as lysine, neither in combination with methionine nor with bypassed methionine.
6. 6. The method of claim 5, wherein the amount of lysine fed to the suckling calf is 2 g to 6 g per day.
Citation Information
Patent Citations
JP1975040919A
Mixture of amino acid and inorganic salt for ruminant cattle
JP1984159741A
Feed additive for animal use
JP1993192093A
Supplement of amino acid level for ruminants
JP1994237702A
Anion adjusting agent for ruminant
JP1999029469A
